Navigation Links
Short-Term, Early HRT May Cut Women's Alzheimer's Risk: Study
Date:10/25/2012

By Barbara Bronson Gray
HealthDay Reporter

WEDNESDAY, Oct. 24 (HealthDay News) -- It is said that timing is everything. When it comes to taking hormone replacement therapy, that may indeed be true.

A new study has found that taking hormone replacement therapy within five years of menopause may reduce the risk of developing Alzheimer's disease by 30 percent compared to women who have not used hormone therapy.

The researchers set out to better understand why some previous studies had shown hormones were effective in reducing Alzheimer's risk while others had not.

The Women's Health Initiative Memory Study, a large, multicenter trial, was stopped prematurely in 2002 due to concerns that the hormones might be raising the risks of cardiovascular disease, cancer and dementia.

"The Women's Health study put a cloud over doing further research," said Peter Zandi, author of the latest study and an associate professor at Johns Hopkins University Bloomberg School of Public Health, in Baltimore. "But there was still some mystery: Why were those results so different?"

The new study, performed by a different team of researchers, expanded the previous research by including up to seven years of additional follow-up and more detailed data on the duration, type and timing of hormone therapy.

The new research was published online Oct. 24 in the journal Neurology.

"We found there is likely a critical window after menopause when hormone therapy may be beneficial," Zandi said. "But if started later after menopause, hormones may actually increase the risk of developing Alzheimer's."

Why might that timing be important?

"We don't really know, but we have some ideas," Zandi said. "Around menopause there's a sudden decline in endogenous estrogens, and that may have some provocative effect. Alzheimer's is a chronic disease that most likely has roots in middle age, or earlier." Endogenous estrogens are those that are made naturally by the body.

The researchers followed nearly 1,800 women from Cache County, Utah, aged 65 and older, for 11 years. The participants provided a history of their hormone therapy use and the approximate date when menopause began.

In all, more than 1,100 participants had used hormone therapy, either consisting of estrogen alone or in combination with progestin. During the study, 7.9 percent of the women who had taken hormones developed Alzheimer's disease compared with 13.4 percent of the women who had not.

Although those who had begun hormone therapy within five years of menopause had a 30 percent lower risk of Alzheimer's than those who had not used hormones, a higher risk of dementia was observed among women who had started a combined therapy of estrogen and progestin when they were 65 or older.

The U.S. Preventive Services Task Force, an independent group of national experts in prevention and evidence-based medicine, issued a final statement Oct. 23 recommending against the use of hormone therapy to prevent chronic conditions such as heart disease or dementia in women who had experienced menopause.

Given that recommendation, and the wide range of research about hormone replacement therapy, what should women do?

Dr. Victor Henderson, professor of neurology and health research and policy at Stanford University, said the research shouldn't spur women to take hormone therapy in an effort to cut their risk of getting Alzheimer's.

"I don't think the message is that women of any age should take the hormones to reduce dementia risk," he said.

Henderson, who wrote an accompanying editorial in same journal issue, urged caution: "More research is needed before we can make new recommendations for women about their use of hormone replacement therapy," he said.

More information

Learn more about hormone replacement therapy from the U.S. National Library of Medicine.

SOURCES: Peter Zandi, Ph.D., associate professor, department of mental health, Johns Hopkins University, Baltimore; Victor Henderson, M.D., M.S., professor, health research and policy, and neurology, Stanford University, Palo Alto, Calif.; Oct. 23, 2012, press release, U.S. Preventive Services Task Force; Oct. 24, 2012, Neurology


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Stool Test Might Aid in Early Detection of Colon Cancer
2. An Early Start for Your Child with Autism
3. Early Study Finds Some Promise for Lung Cancer Vaccine
4. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
5. JCI early table of contents for April 9, 2012
6. Eye Tremors May Aid Early Diagnosis of Parkinsons: Study
7. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
8. First contact: Early intervention key in diagnosis and treatment of serious mental illness
9. Brain Tumor Vaccine Shows Promise in Early Trial
10. Role of Screening, Monitoring in Early Kidney Disease Unclear
11. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Short-Term, Early HRT May Cut Women's Alzheimer's Risk: Study
(Date:4/29/2016)... PA (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the ... Prize, the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee ...
(Date:4/29/2016)... ... April 29, 2016 , ... World ... the Gyrociser, an exercise invention which aids in proper muscle development. , "The ... CEO and Creative Director of World Patent Marketing. "Globalization has threatened the future ...
(Date:4/29/2016)... ... 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent ... cancer deaths. More than 10,000 people are expected to die of melanoma this year. The ... the one of the most commonly diagnosed cancers in young women. A recent breakthrough in ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... New York City based oral and ... This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali is ... Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery is ...
(Date:4/29/2016)... Grants Pass, OR (PRWEB) , ... April 29, 2016 , ... ... nutritionists suggest dinner as the meal to miss. That was among the many new ... True Nutrition, on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016   Click here for supplemental ... (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ... agreement to acquire Valley Campus Pharmacy, Inc., doing ... leading specialty pharmacy that provides individualized patient care, ... . In 2015, TNH generated approximately $400 million ...
(Date:4/28/2016)... , April 28, 2016  Marking its one ... breast and ovarian cancer risk test, Color ... 30 genes that highly impact the most common ... today, the Color Test analyzes hereditary cancer risks ... and uterine cancers. The Color Test is physician ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 ... of online consumer insights on healthcare, announced today that ... in their report Cool Vendor in Life Sciences, ... , April 15, 2016.  The report focuses on life-science- ... to gain insight from patients and doctors, confirm medication ...
Breaking Medicine Technology: